Format

Send to

Choose Destination
Med Res Rev. 2004 Mar;24(2):127-50.

Dihydropteridine reductase deficiency in man: from biology to treatment.

Author information

1
Department of Pediatrics, University of Torino, Italy. alberto.ponzone@unito.it

Abstract

In 1975, dihydropteridine reductase (DHPR) deficiency was first recognized as a cause of tetrahydrobiopterin (BH(4)) deficiency, leading to hyperphenylalaninemia (HPA) and impaired biogenic amine deficiency. So far, more than 150 patients scattered worldwide have been reported and major progresses have been made in the understanding of physiopathology, screening, diagnosis, treatment, and molecular genetics of this inherited disease. Present knowledge on different aspects of DHPR deficiency, largely derived from authors' personal experience, is traced in this article.

PMID:
14705166
DOI:
10.1002/med.10055
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center